Skip to main content
. 2003 Nov 7;53(4):331–337. doi: 10.1007/s00262-003-0441-4

Fig. 1.

Fig. 1

Inhibition of CEA peptide-specific proliferative T cell response by MHC class I and MHC class II monoclonal antibodies in patients nos. 6 and 7 vaccinated with rCEA and the adjuvant cytokine GM-CSF. PBMC were stimulated by the CEA-derived peptides 32 and 62, respectively, in the presence of anti-MHC class I, anti-MHC class II or a control mAb (see Materials and methods). Values are given as per cent inhibition